Generic drug
Ticagrelor price, strengths & recalls
Generic of Brilinta
Pharmacies pay $7.29 for 30 tablets of Ticagrelor 90 mg tablet this week, and from $7.29 to $7.87 across its 2 priced strengths and forms. 21 manufacturers make it. It has 2 recalls on record, none ongoing. Its official label last changed on November 17, 2025.
Generic- Fair cash price
- $18.88
- Strengths
- 2
- Makers
- 21
- Updated
- Nov 11
Ticagrelor price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 60 mg tablet | $0.2624 | $7.87 / 30 tablets |
| 90 mg tablet | $0.2429 | $7.29 / 30 tablets |
Brand names of ticagrelor
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
What people paid for Ticagrelor
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use TICAGRELOR TABLETS safely and effectively. See full prescribing information for TICAGRELOR TABLETS. TICAGRELOR tablets, for oral use Initial U.S. Approval: 2011
WARNING: BLEEDING RISK
Ticagrelor tablets, like other antiplatelet agents, can cause significant, sometimes fatal bleeding (5.1, 6.1).
Do not use ticagrelor tablets in patients with active pathological bleeding or a history of intracranial hemorrhage (4.1, 4.2).
Do not start ticagrelor tablets in patients undergoing urgent coronary artery bypass graft surgery (CABG) (5.1, 6.1).
If possible, manage bleeding without discontinuing ticagrelor tablets. Stopping ticagrelor tablets increases the risk of subsequent cardiovascular events (5.2).
WARNING: BLEEDING RISK
See full prescribing information for complete boxed warning.
Ticagrelor tablets, like other antiplatelet agents, can cause significant, sometimes fatal bleeding. (5.1, 6.1)
Do not use ticagrelor tablets in patients with active pathological bleeding or a history of intracranial hemorrhage. (4.1, 4.2)
Do not start ticagrelor tablets in patients undergoing urgent coronary artery bypass graft surgery (CABG). (5.1, 6.1)
If possible, manage bleeding without discontinuing ticagrelor tablets. Stopping ticagrelor tablets increases the risk of subsequent cardiovascular events. (5.2)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA022433 · Astrazeneca
- First approved
- July 20, 2011 (15 years ago)
- Latest approved change
- May 7, 2026
- Approved label
- PDF, May 18, 2026
- Generic makers
- 16 approved generic applications on the market
- Last patent listed
- July 27, 2036
Ticagrelor questions
How much does ticagrelor cost without insurance?
Pharmacies pay about $7.29 for 30 tablets of ticagrelor 90 mg tablet ($0.2429 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $18.88. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of ticagrelor?
Ticagrelor is sold as Brilinta. The generic has the same active ingredient and usually costs far less.
Is ticagrelor in shortage?
No shortage is reported for ticagrelor right now. We check the national shortage list every day.
Has ticagrelor been recalled?
2 recalls on record, none ongoing. Recalls name specific lots - check yours.
When did the ticagrelor label last change?
The official label was last updated on November 17, 2025 (version 10). See what changed.
Talk about ticagrelor
No comments yet. Questions, tips, what worked for you - start the conversation.